Demant AS
DEMANT: XCSE (DNK)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
DKK 135.00 | Bysfzgv | Gxyhjdhxk |
Communications Drags Down Demant Throughout 2022
We anticipate a moderate decrease to our fair value estimate for narrow-moat Demant, given the weakness in the hearing healthcare market that prevailed through the end of 2022 on top of the lackluster gaming market. Organic revenue growth for the full year was 4%, heavily supported by the diagnostics and hearing aid segments, which saw organic growth of 13% and 9%, respectively. The communications segment saw a negative organic impact of 13% year over year.